Home Blog Page 2629

LG INTRODUCES INTELLIGENT, INNOVATIVE CLEANING WITH NEW VACUUMS AT IFA 2025

By
Advertorial Desk
-

Tailored for the European Market, Company’s New Range of Vacuum Solutions Offers Enhanced Convenience and Performance

SEOUL, South Korea, Aug. 28, 2025 /PRNewswire/ — LG Electronics (LG) is showcasing four new vacuum cleaning solutions designed expressly for the European market at IFA 2025. The lineup includes a robot vacuum with steam mop, a built-in robot vacuum station, a stick vacuum and a wet-dry stick vacuum. Offering enhanced convenience, powerful performance and seamless design, LG’s latest innovations reaffirm the brand’s commitment to making everyday life easier for customers across Europe.

LG showcases a range of new vacuum cleaning solutions offering enhanced convenience and performance at IFA 2025.
LG showcases a range of new vacuum cleaning solutions offering enhanced convenience and performance at IFA 2025.

Deep Clean Meets Everyday Comfort

Significantly upgraded from its predecessor, the new LG robot vacuum raises the bar for home cleaning solutions with advanced features, functionality and the satisfaction of aesthetically blending into your home with its furniture-like looks. Its steam mopping capability effectively removes grease and liquid spills, while the freestanding, furniture-like docking station self-sterilizes the mop with hot water and steam, keeping it clean and odor-free after each use. With more than double the suction power of last year’s model, it delivers a deeper clean on both hard and carpeted floors.

Equipped with an on-device AI chip, the robot vacuum recognizes a range of environmental factors – from dirt and dust to furniture and other household objects – enabling more precise navigation and cleaning. Its AI carpet detection system automatically returns the vacuum to the docking station to detach the mop when carpeted areas are detected, helping prevent staining and improving cleaning efficiency. Stylish yet practical, the docking station blends seamlessly with any interior for a clean, modern look. Furthermore, the new robot vacuum incorporates the LG Shield security platform to keep customers’ data safe and secure.

Hidden Fit, Hands-free Experience

Developed with European homes in mind, LG’s built-in robot vacuum station is designed to fit neatly into unused space beneath the kitchen sink, enabling a tidy and space-efficient installation. An auto-opening door, nearly invisible when closed, allows the vacuum to enter and return without user intervention, helping maintain a minimalist kitchen aesthetic.

The built-in station features an air circulation system that dampens noise during automatic dust disposal, helping preserve a quieter indoor environment. It also offers a fully automated, hands-free experience with auto water supply and draining. In addition, a turbidity sensor monitors mop cleanliness in real time and automatically initiates washing when soiling is detected, ensuring thorough, efficient cleaning with less energy use.

Enduring Performance

Unlike conventional cordless vacuums that often lose suction due to clogging from pet hair and fine dust, LG’s new stick vacuum provides consistent, powerful performance. Its Micro Cyclone technology and new filter cleaning system delivers stable suction power every time.

Building on its predecessor’s allergy-aware design, the model includes an auto dust disposal system that minimizes exposure to dust particles when emptying the bin. Additionally, it includes a compact, free-standing storage and recharging station with a small footprint, allowing users to conveniently place it almost anywhere in their home.

Effortless Cleaning and Care

LG is also introducing its new wet-dry stick vacuum, a product that meets growing consumer demand throughout Europe for a lighter, more convenient cleaning solution. Lightweight and easy to maneuver, it helps reduce wrist strain and fatigue during cleaning. The AI Roller Control function further lessens the burden on users’ wrists and contributes to overall ease-of-operation, ensuring the vacuum moves smoothly when pushed and pulled across different surfaces.

Combining advanced capabilities of LG’s AI technology, the vacuum learns from users’ cleaning patterns to optimize efficiency. Its roller delivers powerful suction that lifts both liquid messes – such as sauces – and larger solid particles like cereal and pet food. Built-in LED lighting helps users spot debris in low-light conditions. For hygiene, the mop head undergoes hot water washing, steam sterilization and hot air drying – keeping the mop head fresh and the vacuum clean.

“LG’s new vacuums are designed for European homes and lifestyles, delivering reliable performance along with greater comfort, hygiene and peace of mind,” said Lyu Jae-cheol, president of the LG Home Appliance Solution Company. “We are committed to introducing innovations that meet the diverse needs of our customers and create effortless ease and elegance in everyday life.”

LG’s latest vacuum lineup and other home appliance solutions will be on display at the company’s IFA 2025 exhibition booth (Hall 18, Messe Berlin) in Berlin, Germany, from September 5-9.

About LG Electronics Home Appliance Solution Company 

The LG Home Appliance Solution Company (HS) is a global leader in home appliances and AI home solutions. By leveraging industry-leading core technologies, the HS Company is committed to enhancing consumers’ quality of life and promoting sustainability. The company develops thoughtfully designed kitchen and living appliance solutions and has recently integrated LG’s Robot Business Division to incorporate advanced robot technologies into its home solutions. Together, these products offer enhanced convenience, exceptional performance, efficient operation and sustainable lifestyle solutions. For more news on LG, visit www.LGnewsroom.com.

 

The new LG robot vacuum features AI-powered navigation and steam mopping in a stylish design that blends naturally with the home interior.
The new LG robot vacuum features AI-powered navigation and steam mopping in a stylish design that blends naturally with the home interior.

LG’s built-in robot vacuum station fits seamlessly under a kitchen sink, offering a hidden and hands-free cleaning solution.
LG’s built-in robot vacuum station fits seamlessly under a kitchen sink, offering a hidden and hands-free cleaning solution.

LG introduces two new stick vacuums that deliver powerful, convenient, and enhanced cleaning performance.
LG introduces two new stick vacuums that deliver powerful, convenient, and enhanced cleaning performance.

Fujitsu develops AI agent platform for the healthcare sector to enhance operational efficiency and ensure stable medical service provision

By
Advertorial Desk
-

TOKYO, Aug. 28, 2025 /PRNewswire/ — Fujitsu today announced the development of a secure and efficient AI agent platform to accelerate operational efficiency and ensure stable medical service provision in Japan’s healthcare sector. The new platform includes an orchestrator AI agent, a centralized system that supports the collaboration and coordination of multiple specialized healthcare-specific agents developed by Fujitsu and other partner companies. The initiative aims to contribute to the rapid implementation of world-leading medical operational practices, thereby driving business transformation and improving sustainability within Japan’s healthcare industry. The development of this platform was supported by NVIDIA, a global leader in accelerated computing and foundational AI agent technology.

In 2025, Fujitsu will accelerate commercialization of the platform by collaborating with advanced medical institutions and partners around the world to verify the effectiveness of the newly developed healthcare orchestrator AI agent and develop specific industry-focused AI agents.

Moving forward, under its Fujitsu Uvance business model, which aims to address societal challenges, Fujitsu will continue to transform healthcare and drug discovery through data and AI, realizing a society where personalized treatment opportunities are available to everyone and advancing the well-being of individuals.

Overview of the new AI agent platform

Fujitsu will provide a suite of task-specific AI agents for medical workflows through the AI agent platform, leveraging its extensive operational knowledge in healthcare and broad collaborations with medical institutions. This platform can seamlessly integrate a wide range of AI agents, including those for data structuring and interoperability monitoring, and flexibly incorporates partner-developed healthcare-specific AI agents. This comprehensive approach supports broad and rapid transformation of operational processes.

To streamline complex operations, AI agents must collaborate effectively. Fujitsu’s healthcare orchestrator AI agent implemented in this platform centrally controls and automates medical operational workflows both within and outside institutions, and can autonomously combine and utilize various specialized medical applications.

By combining Fujitsu’s deep operational knowledge of Japanese medical information systems with NVIDIA’s leading agentic AI technology, such as NVIDIA NIM microservices and NVIDIA Blueprints, Fujitsu aims to support the implementation of world-leading medical operational practices.

For full release click here

 

Meet the Roborock H60 Hub Ultra: Cordless Cleaning with Auto-Empty Ease

By
Advertorial Desk
-

Roborock launches the H60 Hub Ultra cordless stick vacuum in Australia, delivering deep-cleaning performance with hands-free dust disposal for the ultimate everyday convenience.

SYDNEY, Aug. 28, 2025 /PRNewswire/ — Roborock, a global leader in ultra-intelligent home robotics, is raising the bar for cordless vacuuming in Australia with the launch of the H60 Hub Ultra. Blending powerful suction, long-lasting battery life, and Roborock’s latest self-emptying dock technology, the H60 Hub Ultra is built to take the effort out of deep cleaning – and keep homes effortlessly spotless with minimal maintenance.


“At Roborock, we believe that smart cleaning should be seamless and fit effortlessly into everyday life,” said Richard Chang, Founder & CEO of Roborock. “With the H60 Hub Ultra, we’re combining flagship-level power with the convenience of automatic dust disposal, so Australians can spend less time on chores and more time doing what they love. It’s about delivering a smarter, more hygienic clean without the usual hassle — a vacuum that truly works for you.”

Deep Cleaning Meets Cordless Convenience

The H60 Hub Ultra delivers a powerful 210AW of suction, enough to lift embedded dust and debris from deep within carpets and along hard floor edges. Backed by TÜV Rheinland certification, it offers robust, reliable cleaning with up to 90 minutes of runtime on a single charge, giving users the freedom to clean large areas without interruption. Its lightweight build and telescopic wand make it easy to manoeuvre, while the detachable battery provides flexible charging options and extended runtime when needed.

Smarter Storage with Auto-Empty Dock

Say goodbye to messy dustbins and hello to true convenience. The H60 Hub Ultra’s auto-empty dock takes care of dust disposal in just 10 seconds, transferring debris into a 3L sealed dust bag that holds up to 100 days’ worth of dirt. Once docked, the vacuum also recharges automatically, ready for the next clean. With an ergonomic docking height of 848mm and retractable wand design, docking is simple and comfortable — no awkward lifting required.

See the Dust, Clean with Confidence


Cleaning just got smarter with the H60’s 140° wide-angle green dust detection light, which illuminates hidden dirt and dust across a broad path so nothing gets missed. Whether you’re vacuuming under furniture or across high-traffic areas, this clever light helps ensure a more thorough, consistent clean every time.

Designed for a More Hygienic Home

The sealed dust bags on the H60 Hub Ultra are designed to trap 99% of bacteria, helping keep dust and allergens securely contained. Inside the vacuum, a 5-stage filtration system, including a HEPA filter, captures 99.95% of microdust particles as small as 0.3 microns, while a 9-cyclone separation system maintains strong, steady suction by preventing clogs. It’s everything you need for a cleaner home, and cleaner air.

Built to Tackle Every Mess


The H60 Hub Ultra comes with a complete range of versatile attachments to take on any surface or situation. The JawScrapers™ anti-tangle brush, which achieves a 0% tangle rate, features a curved shark-tooth design and fibre-rubber roller to actively prevent hair wrap — ideal for pet owners and long-haired households. A motorised mini-brush makes short work of upholstery and mattresses, while the 2-in-1 crevice tool is perfect for corners, baseboards, and other hard-to-reach spots. And with built-in dock storage, your tools stay organised and within reach.

Pricing and Availability

The Roborock H60 Hub Ultra will be available in Australia from 28 August 2025 at RRP $999 through Roborock’s Official Online Store and Participating Online Retailers.

For more information, visit: https://au.roborock.com

About Roborock
Roborock is a leading smart cleaning brand renowned for its intelligent cleaning solutions. With a steadfast dedication to becoming a global leader in smart appliances, Roborock enriches lives with its innovative line of robotic, cordless, wet/dry vacuum cleaners, and washer-dryers. Rooted in a user-centric approach, our R&D-driven solutions cater to diverse cleaning needs in over 15 million homes across 170+ countries. Headquartered in Beijing and with strategic subsidiaries worldwide, including the United States, Japan, Germany, and Australia, Roborock is committed to simplifying the way the world cleans.

 

Harvest Accounting Secures Double Win at Xero Asia Awards 2025

By
Advertorial Desk
-

SINGAPORE, Aug. 28, 2025 /PRNewswire/ — Harvest Accounting, a Singapore-based accounting practice that helps small businesses manage their finances online, has won Digital Innovator of the Year and Partner of the Year – Singapore at the Xero Asia Awards 2025 on August 7. The double win highlights how the firm is using cloud technology to cut paperwork, simplify day-to-day finance, and give small businesses clearer insights into their performance.

Mr Bryan Zhao (in blue), Mr Matthew Phua (in taupe), Founding Partners of Harvest Accounting and their team celebrating the double wins at the Xero Asia Awards 2025 on 7 Aug.
Mr Bryan Zhao (in blue), Mr Matthew Phua (in taupe), Founding Partners of Harvest Accounting and their team celebrating the double wins at the Xero Asia Awards 2025 on 7 Aug.

Xero is a cloud accounting platform used by more than 4 million subscribers worldwide. Its annual Asia Awards recognise outstanding accounting and bookkeeping partners across the region, based on achievements in the past 12 months. Winners are chosen through a two-step judging process involving Xero leaders and external industry specialists. With hundreds of eligible firms and only a handful named as finalists, competition is strong.

The Digital Innovator of the Year award recognises firms that have transformed their operations through technology. Harvest was commended for migrating more than 140 clients onto Xero with support from Singapore’s Productivity Solutions Grant, and for extending the platform’s impact with connected apps. This includes Syft, a third-party tool that converts Xero data into visual dashboards and reports, and Dext, which captures receipts and invoices and sends the data straight into Xero to cut out manual entry. Harvest is also embracing AI, using it in its first-layer review checklist process to save time and improve consistency for its clients. It is currently the only Singapore firm in Xero’s Early Adopters Hub, where new tools are tested before wider release.

The Partner of the Year – Singapore award recognises firms making a strong impact in the local market. In Singapore alone, there are more than 280 certified Xero advisors, underscoring the significance of Harvest being singled out. In particular, the launch of its “It’s a Great Day to Harvest” campaign showcased stories from small business clients and how cloud accounting supports their growth, encouraging adoption of a tool that would transform how they keep their accounts.

To mark the double win, Harvest is offering one month of services free for new clients who sign up for a yearly accounting package by 31 December 2025.

Ms Koren Wines, Managing Director, Xero APAC said: “Watching Harvest win both Partner of the Year for Singapore and Digital Innovator of the Year has been wonderful. They represent what we love about our partners: they’re innovative, client-focused and genuinely care about helping small businesses succeed. This double recognition is well-deserved and a testament to their position as one of Singapore’s most trusted accounting practices.” 

Mr Matthew Phua, Founding Partner, Harvest Accounting said: “Being recognised by Xero with two awards is strong validation of our mission to help small businesses win. From streamlining finance to reimagining workflows and harnessing cloud and AI tools, we’ve built Harvest to give clients an edge: Less admin, clearer numbers, and faster decisions. These awards affirm that our focus on technology is the right way forward, keeping businesses lean and adaptable.”

Mr Bryan Zhao, Founding Partner, Harvest Accounting added: “Our clients want more than reports; they want clarity and confidence. At Harvest, we translate what’s in the cloud into tangible value, making insights simple and actionable. By marrying Xero’s strong suite of tools with our expertise and hands-on support, we help small businesses stay on top of their finances and grow with confidence.”

For more information on how Harvest Accounting can help your business thrive, visit harvestaccounting.com.sg.

ABOUT HARVEST ACCOUNTING

Founded in 2018, Harvest Accounting is a digital-first practice built fully in the cloud with a mission to help small businesses win. The firm focuses on streamlining operational finance, reimagining workflows, and identifying the right tools from the Xero app ecosystem to deliver efficiency, clarity, and collaboration. Today, Harvest supports more than 500 companies across Singapore and continues to grow its client base with technology-led solutions.

MEDIA CONTACT

media@harvestaccounting.com.sg

AIM Vaccine Forecasts Surge in Stock Performance: Innovations Reinforce Leadership in Vaccine Sector

By
Advertorial Desk
-

HONG KONG, Aug. 28, 2025 /PRNewswire/ — AIM Vaccine (06660.HK), a leading domestic vaccine company, announced today the release of its 2025 interim report, showcasing robust revenue growth. With major products entering the market phase, R&D costs are decreasing, and operational expenditures are being optimized. Four core innovative products are poised for commercialization, and significant advancements have been made in overseas market expansion. Two mRNA technology vaccines have simultaneously received clinical trial approvals in both the PRC and the U.S., leading to optimistic forecasts from institutions. A recent report[1] by DBS Bank predicts nearly 60% upside potential for the company’s stock price compared to current levels.

Confirmed Major Products Expected to Achieve Profitability by 2026

According to the interim report, AIM’s 13-valent pneumococcal conjugate vaccine has applied for market registration and completed on-site verification. The application for its serum-free rabies vaccine has been accepted, while the 23-valent pneumococcal polysaccharide vaccine has finished Phase III clinical serological tests and is set to enter the statistical unblinding phase. The iterative process for the high-efficiency diploid rabies vaccine is currently in Phase III clinical trials, expected to conclude by the end of 2025, with a market registration application planned for 2026.

DBS Bank’s research report forecasts that AIM Vaccine is likely to achieve profitability by 2026. By then, AIM is projected to become the leading manufacturer of rabies and pneumococcal vaccines in the PRC, capturing approximately 20% and 10% market shares, respectively. Sales from 2025 to 2027 are anticipated to grow at a compound annual growth rate of 45%.

mRNA Technology Platform Gains International Recognition, Leading R&D Innovation in the Industry

As highlighted in the interim report, AIM Vaccine continues to excel in R&D, currently possessing 20 vaccine products in development targeting 12 diseases, with 23 clinical approvals and 24 clinical trials underway. Among these, seven are Category I innovative vaccines, with three having received approval to commence clinical trials. Notably, the mRNA shingles vaccine and mRNA respiratory syncytial virus vaccine have both obtained clinical approval in the U.S. and PRC, marking international validation of the company’s mRNA technology platform.

AIM has also laid plans for mRNA rabies and influenza vaccines, which hold significant market potential. The mRNA rabies vaccine is characterized by a notable reduction in vaccination doses, higher protective neutralizing antibodies, faster production speeds, and strong immune persistence.

Given the platform’s advancement and maturity, AIM’s mRNA technology has been validated through thousands of clinical trial subjects, confirming its safety and efficacy and laying a solid foundation for future mRNA vaccine developments.

Moreover, amid the trend of innovative drug exports, AIM Vaccine has showcased its strengths. In the first half of the year, the company’s quadrivalent meningococcal polysaccharide vaccine successfully entered the African market, the rabies vaccine debuted in Central America, the hepatitis B vaccine is actively progressing through registration processes in Southeast Asia, and the hepatitis A vaccine is advancing registration in South Asia. The registration work for the quadrivalent meningococcal polysaccharide vaccine in Central Asia is also steadily progressing, with local market entry expected next year.

Meanwhile, AIM is actively preparing for the internationalization of the 13-valent pneumococcal conjugate vaccine and the serum-free rabies vaccine, having secured exclusive agency agreements with multiple countries in West and Southeast Asia. A formal memorandum of understanding for the 13-valent pneumococcal conjugate vaccine has been signed with Egypt, further expanding its market presence in the Middle East and North Africa.

With strong technological innovation represented by mRNA, several major products nearing commercialization, and broad overseas market strategies, AIM Vaccine has garnered optimistic expectations from institutions. The DBS report predicts that performance turning points will drive a reassessment of AIM Vaccine’s stock price, estimating a fair value of HKD 8.3 per share, indicating nearly 60% upside potential compared to current levels.

Currently, the enthusiasm for innovative drugs in the capital market remains strong. Multiple investment institutions believe that with favorable industry policies and capital enthusiasm, companies with genuine innovative capabilities are expected to experience significant market value growth. As an industry leader, AIM Vaccine is well-positioned to navigate an optimistic market amid the convergence of performance and valuation.

 

Ascletis Announces Favorable and Differentiated Pharmacokinetic Profile of ASC30 Oral Once-Daily Tablet in Its U.S. Phase Ib Multiple Ascending Dose Study

By
Advertorial Desk
-

–          ASC30 oral once-daily tablet demonstrated approximately 2.3-fold to 3.3-fold greater drug exposure than orforglipron in a cross-trial comparison.

–          Higher drug exposure and favorable tolerability profile positions ASC30 oral once-daily tablet favorably compared to orforglipron.

–         Topline data from the Ascletis’ U.S. Phase IIa study for ASC30 in participants with obesity or overweight are expected in the fourth quarter of 2025.

HONG KONG, Aug. 28, 2025 /PRNewswire/ — Ascletis Pharma Inc. (HKEX:1672, “Ascletis”) today announces promising topline pharmacokinetic (PK) data from its randomized, double-blind, placebo-controlled Phase Ib multiple ascending dose (MAD) study (NCT06680440), conducted in the U.S., of ASC30 oral once-daily tablet in participants with obesity (body mass index (BMI): 30-40 kg/m2). At steady state, ASC30 demonstrated drug exposures (area under the curve over 0-24 hours or AUC0-24h) of 3,560 ng•h/mL and 5,060 ng•h/mL for cohort 1 (20 mg) and cohort 2 (40 mg) , respectively, in the Phase Ib MAD study. These drug exposure data are consistent with placebo-adjusted mean body weight reduction from baseline of 4.5% for cohort 1 (20 mg) and 6.5% for cohort 2 (40 mg) after 28-day treatment, indicating higher drug exposures are associated with greater weight loss.

Based on a cross-trial comparison, 20 mg and 40 mg ASC30 oral once-daily tablet demonstrated greater drug exposure of approximately 2.3-fold and 3.3-fold, respectively, of orforglipron oral once-daily capsule (24 mg cohort, AUC0-24h 1,520 ng•h/mL) [1]. After 28-day treatment, orforglipron (24 mg cohort, AUC0-24h 1,520 ng•h/mL) resulted in only 3.6% placebo-adjusted mean body weight reduction from baseline [1]. Despite high drug exposure of ASC30 in cohort 1 (20 mg, AUC0-24h 3,560 ng•h/mL), there were no incidences of vomiting in cohort 1 (20 mg), whereas orforglipron 24 mg cohort (AUC0-24h 1,520 ng•h/mL) had 18% vomiting[1], suggesting the Ascletis’ chemical lead and formulation optimization strategies played a role in tolerability improvement.

In the Phase Ib MAD study, ASC30 oral once-daily tablet was safe and well tolerated with no serious adverse events (SAEs) reported and no Grade 3 or higher adverse events (AEs) including GI-related AEs observed. There were no elevations of liver enzymes including alanine aminotransferase (ALT), aspartate aminotransferase (AST) and total bilirubin (TBL) during the treatment. There were no abnormal findings in laboratory tests, vital signs, ECGs (electrocardiograms, including QTc intervals), and physical exams.

“Based on recent clinical data published to date, we believe higher drug exposure leads to greater weight loss for small molecule GLP-1 receptor (GLP-1R) agonists including orforglipron,” said Jinzi Jason Wu, Ph.D., Founder, Chairman and CEO of Ascletis. “I am pleased to see that the higher drug exposures of ASC30 seen in a head-to-head study in non-human primates with orforglipron translated to humans at approximately 2.3-fold to 3.3-fold greater than orforglipron in a cross-trial comparison. Given that higher drug exposures of ASC30 produced more weight loss in participants with obesity, we believe that ASC30 oral once-daily tablet may potentially be competitive and differentiated for the treatment of obesity compared to orforglipron.”

Ascletis announced in early August 2025 that it completed enrollment in its U.S. Phase IIa study for ASC30 in 125 participants with obesity or overweight, with topline data expected in the fourth quarter of 2025.

[1] Pratt E, Ma X, Liu R, et al. Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: A Phase 1a, blinded, placebo-controlled, randomized, single- and multiple-ascending-dose study in healthy participants. Diabetes Obes Metab. 2023;25(9):2634‐2641. doi:10.1111/ dom.15184.

About ASC30

ASC30 is an investigational GLP-1R biased small molecule agonist and has unique and differentiated properties that enable the same small molecule for both oral tablet and subcutaneous injection administrations. ASC30 is a new chemical entity (NCE), with U.S. and global compound patent protection until 2044 without patent extensions. 

About Ascletis Pharma Inc.

Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases. Utilizing its proprietary Artificial Intelligence-Assisted Structure-Based Drug Discovery (AISBDD) Platform and Ultra-Long-Acting Platform (ULAP), Ascletis has developed multiple drug candidates in-house, including its lead program, ASC30, a small molecule GLP-1R agonist in development as a once-daily oral tablet and once-monthly subcutaneous injection for weight management. Ascletis is listed on the Hong Kong Stock Exchange (1672.HK).

To learn more about Ascletis, please visit www.ascletis.com.

Contact：

Peter Vozzo
ICR Healthcare
443-231-0505 (U.S.)
Peter.vozzo@icrhealthcare.com

Ascletis Pharma Inc. PR and IR teams
+86-181-0650-9129 (China)
pr@ascletis.com
ir@ascletis.com 

SK hynix Starts Supplying Mobile DRAM with Highly Efficient Heat Dissipation

By
Advertorial Desk
-
  • Company first in industry to develop High-K EMC material, improves thermal conductivity by 3.5 times, thermal resistance by 47%
  • Customers expect achievement to help address heat issue generated from on-device AI
  • SK hynix to lead next-generation DRAM for mobile device through technological innovation of materials

SEOUL, South Korea, Aug. 28, 2025 /PRNewswire/ — SK hynix Inc. (or “the company”, www.skhynix.com) announced today that it has started supplying mobile DRAM products with highly efficient heat dissipation by adopting the High-K Epoxy Molding Compound* material for the first time in the industry.

* EMC(Epoxy Molding Compound): a critical material for semiconductor packaging that protects chips from various external conditions such as water, heat, impact and electronic charge and provides a channel where heat can be dissipated. High-K EMC raises thermal conductivity with adoption of a material with high heat-transfer coefficient in EMC

The development comes as heat generated in the process of fast data transfer for on-device AI applications results in performance degradation of smartphones. Global smartphone companies welcome the launch of the product on expectations that it will help address the heat issue of high-performance flagship smartphones.

The structure of package on package, or PoP**, that most flagship smartphones adopt and stacks DRAM onto the application processor***, allows efficient use of limited space, while improving data transfer speed. Such system, however, also triggers a performance degradation of the device itself as heat generated within the mobile AP stays inside DRAM.

** PoP(Package on Package): a packaging method commonly used for mobile products. Different types of chips are stacked vertically to improve space efficiency, performance and flexibility of combinations

*** Mobile AP(Application Processor): chip referred to the brain of mobile devices such as smartphones and tablets

SK hynix found the solution in improvement of thermal conductivity of EMC, a critical material that covers DRAM package and developed High-K EMC by adding Alumina to Silica, which has been adopted for EMC material so far.

With thermal conductivity improved by 3.5 times and thermal resistance in the vertical course of the heat improved by 47%, the new technology is expected to contribute to a longer battery runtime and  product lifespan by improving performance of a smartphone and reducing power consumption.

“It’s a meaningful achievement that goes beyond a simple performance improvement as it addresses the inconvenience that many high-performance smartphone users may have had,” Lee Gyujei, Head of Package Product Development, said. “We are committed to firmly establishing our technological leadership in the next-generation mobile DRAM market with our technological innovation in materials.”

About SK hynix Inc.

SK hynix Inc., headquartered in Korea, is the world’s top tier semiconductor supplier offering Dynamic Random Access Memory chips (“DRAM”) and flash memory chips (“NAND flash”) for a wide range of distinguished customers globally. The Company’s shares are traded on the Korea Exchange, and the Global Depository shares are listed on the Luxembourg Stock Exchange. Further information about SK hynix is available at www.skhynix.com, news.skhynix.com.

Henan Launches Global Digital Tourism Platform at Expo 2025 Osaka to Grow Inbound Visitation

By
Advertorial Desk
-

TOKYO, Aug. 27, 2025 /PRNewswire/ — On August 21, 2025, the Culture and Tourism Department of Henan Province introduced its new global digital tourism platform—“Journey of Civilization Light”—in Japan during Expo 2025 Osaka. The launch represents a major step forward in strengthening international cultural and tourism exchange.


During Henan Week at the Expo, more than one thousand promotional brochures and themed giveaways were shared through interactive activities, sparking interest among attendees. Journey of Civilization Light is a digital showcase designed to highlight Henan’s rich cultural legacy, historic landmarks, and scenic landscapes through immersive digital experiences. The platform provides global audiences with an accessible gateway to explore Henan’s attractions in greater depth. At the same time, in-person promotions were carried out in Tokyo in collaboration with leading travel agencies, while the online campaign drew more than ten thousand views. Together, these efforts connected directly with prospective visitors and generated strong demand for Henan’s tourism experiences in the Japanese market.

By building strategic partnerships with travel agencies in Osaka, Tokyo, and other key cities throughout Japan, and by sharing destination information widely, the initiative successfully reached its target audience. With the high profile of Expo 2025 and strong attention from international media, the campaign raised global awareness of the Laojia Henan brand and reinforced the cultural identity of “Henan, Where China Began.” Together, these efforts set the stage for continued growth in inbound travel to Henan.

1...2,6282,6292,630...6,490Page 2,629 of 6,490